IndraLab

Statements


USP29 ubiquitinates MAP3K7. 1 / 1
| 1

reach
"Mechanistically, USP29 reduces the sterile inflammation and hepatocellular damage by deubiquitinating TAK1 and preventing its phosphorylation, thereby suppressing the activation of its downstream JNK/p38 pathways."